readthroughSign in
CompanySRPTNasdaqCambridge, MA

Sarepta Therapeutics, Inc.

Sarepta develops genetic medicines for rare diseases, with a focus on Duchenne muscular dystrophy.

10-QNov 16Latest SEC filing
Nov 3Latest story